Ellevest, Inc. Invitae Corp Transaction History

Ellevest, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$1.71 - $3.61 $976 - $2,061	-571 Reduced 11.26%	4,500 $8,000
Q3 2022 Nov 02, 2022	BUY	$1.9 - $8.63 $758 - $3,443	399 Added 8.54%	5,071 $12,000
Q2 2022 Jul 18, 2022	BUY	$2.13 - $9.01 $366 - $1,549	172 Added 3.82%	4,672 $11,000
Q4 2021 Jan 24, 2022	SELL	$14.7 - $28.67 $2,543 - $4,959	-173 Reduced 3.7%	4,500 $69,000
Q3 2021 Oct 19, 2021	BUY	$24.31 - $33.6 $2,285 - $3,158	94 Added 2.05%	4,673 $133,000

Q2 2021 Jul 13, 2021	SELL	$26.09 - $40.4 $1,174 - $1,818	-45 Reduced 0.97%	4,579 $154,000
Q1 2021 May 03, 2021	BUY	$33.06 - $56.93 $495 - $853	15 Added 0.33%	4,624 $177,000
Q4 2020 Feb 04, 2021	BUY	$39.09 - $57.4 $177,468 - $260,596	4,540 Added 6579.71%	4,609 $193,000
Q3 2020 Oct 26, 2020	BUY	$28.43 - $44.67 $1,535 - $2,412	54 Added 360.0%	69 $3,000
Q2 2020 Jul 06, 2020	SELL	$11.71 - $30.29 $234 - $605	-20 Reduced 57.14%	15 $0
Q1 2020 Apr 13, 2020	BUY	$7.64 - $27.5 $22 - $82	3 Added 9.38%	35 $0
Q4 2019 Feb 05, 2020	BUY	$15.02 - $20.57 $480 - $658	32 New	32 $1,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.